Navigation Links
Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas
Date:11/8/2010

rivate healthcare expenditures.

• The challenges encountered in these markets are also numerous and include diverse languages and cultures, healthcare regulations, distribution challenges, preferential treatment for domestic companies and healthcare cost containment measures.

Key findings from this report- The vast opportunities for Pharmaceuticals in China appear more attainable than ever given the government's funding of major Healthcare Reforms to increase healthcare access, infrastructure and services between 2009 and 2011. These healthcare reforms aimed at expanding medical insurance and access while decreasing costs are expected to increase pharmaceutical volume at reduced prices.

- India, with its population of 1.1 billion, high levels of poverty and unmet medical needs and low healthcare expenditures continues to present challenges for the global industry. Opportunities include manufacturing skills including Biosimilar manufacturing. However, the lack of Intellectual Property recognition for several biologics, that prompted Novartis's shift of R+D investment from India to China, is a concern for the innovative industry.

- The large market shares of generics in the Emerging markets have resulted in numerous generic supply deals by companies including Pfizer, GSK, Sanofi Aventis, Novartis, Daiichi Sankyo and Abbott. Other companies that are seeking generic portfolios through alliances or acquisitions include Astra Zeneca, Lilly, J&J and Merck.

- Mylan and Teva appear to be potential alliance partners for companies seeking generics, based on their product portfolios and limited Emerging Market presence.

Key questions answered- What are the pharmaceutical market sizes, growth forecasts and unmet medical needs in the Emerging markets?

- Is there one definitive list of Emerging markets for Pharmaceuticals?

- What are the opportunities and challenges presented by the major Emerging Mark
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion
2. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
3. Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum
4. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
5. Burrill & Company and Infinity Group Form Joint Venture Focusing on Life Science Opportunities in China
6. U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan
7. Decision Resources Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars
8. CardioTec Conference to Address Opportunities and Challenges in Cardiovascular Device Manufacturing
9. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
10. Reportlinker Adds Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities
11. Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced the appointment ... Warburg Pincus LLC, to the Amgen Board of Directors. ... and the deep, global experience he brings in the ... Bradway , chairman and chief executive officer of Amgen. "Fred,s breadth ... well." Mr. Hassan has been Partner and Managing ...
(Date:7/30/2015)... CHAGRIN FALLS, Ohio , July 30, 2015 /PRNewswire/ ... in his OMTEC® 2015 keynote address last month that ... business models in order to gain the efficiencies—and develop ... future. Dr. Barsoum,s comments were preceded by ... Tornier, avid entrepreneur and OMTEC moderator, who stressed that ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... (NASDAQ: ARNA ) announced today that ... JMP Securities Healthcare Conference on Tuesday, September 27, 2011, at ... St. Regis New York Hotel in New York City. Jack ... provide a corporate overview. A live audio webcast ...
... Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer ... bioimplants processed from human amniotic membrane, announced today ... national, leading distributor of spine, biologic and other ... Administration ("VA") and Department of Defense ("DOD") facilities. ...
Cached Medicine Technology:Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 2Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 3MiMedx Group Partners With Affirmative Solutions 2MiMedx Group Partners With Affirmative Solutions 3
(Date:8/2/2015)... ... ... A new Phase I research study is looking at a vaccine that hopes ... G. Lucas, M.D. , chief of the division of pediatric hematology/oncology and stem cell ... Hospital and in the UofL Department of Pediatrics . Patients are currently ...
(Date:8/2/2015)... ... August 03, 2015 , ... For many “would be” entrepreneurs, starting a new business can ... can’t afford to start a business.” Neither needs be a major obstacle. , The ... to start a business and be successful. The risks of starting a business can be ...
(Date:8/2/2015)... (PRWEB) , ... August 02, ... ... results when the supportive muscles and connective tissues of a woman’s pelvic ... weakness and damage include straining, heavy lifting, obesity, constipation, multiple vaginal deliveries, ...
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New South Wales ... mesothelioma. Surviving Mesothelioma has just posted an article on the new research. Click ... Wales tested for Ki67 expression in tissue samples from 42 patients with peritoneal mesothelioma ...
(Date:8/1/2015)... ... August 02, 2015 , ... AlignLife Office Coordinator Heather ... continuity of care for patients at this natural health care center in Winamac. , ... Mary Heal said. "Heather's role is vital to our approach because we want to ...
Breaking Medicine News(10 mins):Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:New Patient Advocate Enhances Natural Health Care 2
... of UCSF scientists have received grants from the California ... based strategies for treating diabetes and brain tumors. ... file new drug applications to the U.S. Food and ... clinical trials. The two grants, awarded to collaborative ...
... have DNA that may make things tougher behind the wheel, researchers ... bad driver? Maybe you can blame it on your genes. , ... variation performed 20 percent worse on simulated driving tests and did ... have the variation, the team said. , "These people make more ...
... ... be used to establish the Meharry Clinical and Translational Research Center (MeTRC) to further health ... ... of the National Institutes of Health (NIH), announced today that it will provide $21.4 million ...
... to delays in the nationwide distribution H1N1 flu vaccine, Department ... steps to prevent the spread of illness. , "We ... H1N1 vaccine," Department of Health Deputy Secretary Michael Huff said ... and distribution. "We, too, are frustrated by the production delays. ...
... 29 Although women with chronic hepatitis C virus (HCV) ... compared outcomes for men and women after having liver transplantation ... graft loss and graft loss from recurrent HCV than men. ... HCV and higher risk of developing advanced HCV, our results ...
... energy to stimulate the body,s healing process, are promising ... a number of conditions, reducing anxiety for hospitalized patients ... what standard treatments can achieve. However, longer-term effects are ... of Cancer Prevention and Control Research, and Dr. Paul ...
Cached Medicine News:Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 2Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 3Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 4Health News:Is There a 'Bad Driver' Gene? 2Health News:Meharry Medical College Receives $21.4 Million NIH Research Grant, Largest in Its History 2Health News:Meharry Medical College Receives $21.4 Million NIH Research Grant, Largest in Its History 3Health News:PA Department of Health: National Delays in H1N1 Flu Vaccine Distribution Highlight Need for Continued Prevention Efforts 2Health News:Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease 2Health News:Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease 3Health News:Biofield therapies: Helpful or full of hype? 2
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... from CTS pain and hand tingling in ... CTS treatments. It is not a rigid ... Solution gently reshapes soft tissue in and ... pain, numbness and sleep interruption. It allows ...
Medicine Products: